To validate the scRNA-seq findings, the authors measured serum TGF-β levels in COVID-19 patients and found increased TGF-β concentration in the serum of hospitalized COVID-19 patients at the initial phase of the disease, which was not evident in serum of ambulant COVID-19 or FLI patients. This evidence concerns the gene TGFB1 and COVID-19.